liu.seSök publikationer i DiVA
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry
Uppsala Univ, Sweden.
Skane Univ Hosp, Sweden.
Region Östergötland, Centrum för kirurgi, ortopedi och cancervård, Hematologiska kliniken US.
Sahlgrens Univ Hosp, Sweden.
Visa övriga samt affilieringar
2019 (Engelska)Ingår i: European Journal of Haematology, ISSN 0902-4441, E-ISSN 1600-0609, Vol. 103, nr 2, s. 88-98Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Objectives As new, effective therapies emerge for acute lymphoblastic leukaemia (ALL), the results of clinical trials need to relate to standard of care. Methods We used the population-based Swedish ALL Registry to evaluate characteristics, treatment and long-term outcome in 933 patients with diagnosis between 1997 and 2015. Results The median age was 53 years. The frequency of Philadelphia (Ph)-positive leukaemia was 34% of examined B-ALL with a peak incidence at 50-59 years. Five-year overall survival (OS) improved between 1997-2006 and 2007-2015; in patients 18-45 years from 50% (95% CI 43-57) to 65% (95% CI 58-72), 46-65 years from 25% (95% CI 18-32) to 46% (95% CI 37-55) and amp;gt;65 years from 7% (95% CI 2.6-11) to 11% (95% CI 5.9-16) (P amp;lt; 0.05). Men with Ph-neg B-ALL 46-65 years had inferior OS compared with women (P amp;lt; 0.01). Standardised mortality ratio was 5.7 (95% CI 5.0-6.3) for patients who survived 5 years from diagnosis. In multivariable analysis, Ph-positive disease was not associated with impaired prognosis but with lower risk of death in 2007-2015. Conclusions In a population-based cohort, OS has improved in adult ALL, especially for Ph-positive disease but for middle-aged men with Ph-negative B-ALL outcome was poor. Cure without late toxicity or relapse is still desired.

Ort, förlag, år, upplaga, sidor
WILEY , 2019. Vol. 103, nr 2, s. 88-98
Nyckelord [en]
acute lymphoblastic leukaemia; adult; Philadelphia-positive
Nationell ämneskategori
Hematologi
Identifikatorer
URN: urn:nbn:se:liu:diva-159124DOI: 10.1111/ejh.13247ISI: 000475475200003PubMedID: 31074910OAI: oai:DiVA.org:liu-159124DiVA, id: diva2:1339677
Anmärkning

Funding Agencies|Lions Cancer Foundation Uppsala; Uppsala University; Uppsala County Council/Region agreement on medical training and clinical research (ALF)

Tillgänglig från: 2019-07-30 Skapad: 2019-07-30 Senast uppdaterad: 2019-11-14

Open Access i DiVA

fulltext(688 kB)6 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 688 kBChecksumma SHA-512
f3645ab9e0c185e21dfa51f28261a3fb91369982a2f13b08645139319d5e52f0a2ec6e723d9e3143c54c8dd17d9e85fd9669c082bb8027e6ce9aa586fa56b4c2
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Sök vidare i DiVA

Av författaren/redaktören
Ahlberg, Lucia
Av organisationen
Hematologiska kliniken US
I samma tidskrift
European Journal of Haematology
Hematologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 6 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 22 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf